Canada markets closed

Cidara Therapeutics Inc (20D.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
9.720.00 (0.00%)
At close: 09:00PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
63,905
63,905
64,448
49,572
12,067
Cost of Revenue
1,523
1,523
0
-
-
Gross Profit
62,382
62,382
64,448
-
-
Operating Expenses
Research Development
68,532
68,532
77,405
73,087
68,017
Selling General and Administrative
18,333
18,333
20,546
18,740
15,899
Total Operating Expenses
86,865
86,865
97,951
91,827
83,916
Operating Income or Loss
-24,483
-24,483
-33,503
-42,255
-71,849
Income Before Tax
-22,488
-22,488
-33,312
-42,467
-72,111
Income Tax Expense
443
443
272
0
0
Income from Continuing Operations
-22,931
-22,931
-33,584
-42,467
-72,111
Net Income
-22,931
-22,931
-33,584
-42,467
-72,111
Net Income available to common shareholders
-22,931
-22,931
-33,584
-42,467
-74,873
Basic EPS
-0.43
-5.20
-8.60
-16.20
-36.00
Diluted EPS
-0.43
-5.20
-8.60
-16.20
-36.00
Basic Average Shares
69,858
4,371
3,493
2,623
2,078
Diluted Average Shares
69,858
4,371
3,493
2,623
2,078